A new study shows that artificial intelligence can be used to predict patients' risk of developing a potentially lethal arrhythmia after experiencing heart failure.
Innovation
A retinal imaging platform that uses artificial intelligence to evaluate eye scans for biomarkers of Alzheimer's disease and other neurological disorders has received the FDA's "Breakthrough Device" designation, Canadian startup Optina Diagnostics announced this week.
Aligning lower cost, improved outcomes, a better patient experience, and improved provider satisfaction are the focus of Hospitals today. This summit provided Hospital Executives key insights into the future of Robotic Assisted Surgery and the content shared demonstrated the ability…
A deep learning model trained in mammography is able to predict the development of breast cancer up to five years in advance, according to a study published in Radiology on May 7.
IBM Watson Health Imaging's Patient Synopsis went live at Hardin Memorial Health in Elizabethtown, Ky., on May 6, making the health system the first to implement the artificial intelligence-powered software.
To overcome challenges of fraudulent activity and digital transactions, the insurance industry is beginning to introduce blockchain, which is designed to bring accountability, security and transparency to the industry, according to Yahoo Finance.
The first artificial intelligence-enabled device for diagnosing and managing fast-progressing kidney disease has been granted "Breakthrough Device" designation from the FDA, Cardiff, U.K.-based clinical technology company Renalytix AI announced on May 2.
A new report in Nature details the efforts of scientists at the University of California's San Francisco and Berkeley campuses to translate brain signals into an approximation of natural speech, a groundbreaking process that, with further development, could restore fluent…
AliveCor, the Mountain View, Calif.-based artificial intelligence and medtech company, has received FDA clearance for two more analyses on its AI-powered KardiaMobile electrocardiogram (ECG) device.
A new study published in Science Translational Medicine describes the work of researchers at San Diego's Rady Children's Institute for Genomic Medicine to rapidly diagnose genetic diseases using whole-genome sequencing.